US BANCORP \DE\ - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$964
-82.9%
88
-79.4%
0.00%
Q2 2023$5,653
+60.4%
427
+64.9%
0.00%
Q1 2023$3,525
-83.2%
259
-74.5%
0.00%
Q2 2022$21,000
+162.5%
1,017
+295.7%
0.00%
Q1 2022$8,000
+60.0%
257
+123.5%
0.00%
Q4 2021$5,000
+66.7%
1150.0%0.00%
Q3 2021$3,0001150.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 3,706,663$126,694,00024.48%
MPM BioImpact LLC 2,355,557$80,513,00010.12%
Boxer Capital, LLC 4,345,016$148,513,0005.04%
RA Capital Management 4,417,258$150,982,0002.28%
Ally Bridge Group (NY) LLC 322,794$11,033,0002.12%
Asymmetry Capital Management, L.P. 102,286$3,496,0001.81%
RTW INVESTMENTS, LP 2,762,791$94,432,0001.47%
COWEN AND COMPANY, LLC 588,238$20,106,0001.38%
Artal Group S.A. 1,094,047$37,395,0000.66%
HighVista Strategies LLC 19,804$677,0000.50%
View complete list of ITEOS THERAPEUTICS INC shareholders